Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
nCino, Piper Sandler
nCino stock slides 12% after soft Q4 guidance, Piper downgrade
Cino (NASDAQ:NCNO) stock dropped 12% in late Thursday trading after the company issued weak guidance for Q4 revenue late Wednesday. Piper Sandler downgraded the stock to Neutral from Overweight, citing revenue headwinds for the full year.
Piper Sandler Downgrades nCino (NCNO)
Fintel reports that on December 5, 2024, Piper Sandler downgraded their outlook for nCino (NasdaqGS:NCNO) from Overweight to Neutral. Analyst Price Forecast Suggests 2.29% Downside As of December 3, 2024,
nCino downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded nCino (NCNO) to Neutral from Overweight with an unchanged price target of $38. The firm says elevated churn within
Corbus, Viking initiated at overweight by Piper Sandler
Piper Sandler has initiated coverage of Corbus Pharmaceuticals (CRBP) and Viking Therapeutics (VKTX) with overweight ratings. Read more here.
1d
on MSN
Piper Sandler: Pure Storage hyperscaler win creates 'pure opportunity'
Piper Sandler upgraded Pure Storage (NYSE:PSTG) from Neutral to Overweight following a significant design win with a top-4 ...
Yahoo Finance
14h
Teladoc price target raised to $13 from $11 at Piper Sandler
Piper
Sandler
raised the firm’s price target on Teladoc (TDOC) to $13 from $11 and keeps an Overweight rating on the ...
7h
Campbell's Company Faces Potential Earnings Risk Due To Consumer Challenges: Analysts
Analysts express concerns over consumer challenges for Campbell's Company (CPB), lowering EPS estimates while noting ...
bovnews
13h
What’s Behind the 4.24% Gain in Humacyte Inc (HUMA) Stock? Find Out Now!
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 19.40% ...
Yahoo Finance
14h
Okta price target raised to $90 from $85 at Piper Sandler
Piper
Sandler
raised the firm’s price target on Okta (OKTA) to $90 from $85 and keeps a Neutral rating on the shares. A ...
7h
Teva Pharmaceutical (TEVA) Gets a Buy from Piper Sandler
Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of ...
14h
Piper Sandler上调Robinhood目标价至54美元,维持增持评级
周三,Piper Sandler调整了对Robinhood Markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
nCino
NCNO
Trade
NASDAQ
Chewy
Feedback